Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N-(4-(1-cyclobutylpiperidin-4-yloxy)phenyl)-2-(morpholin-4-yl)acetamide Dihydrochloride
2. Samelisant
3. Suvn-g3031
1. Samelisant
2. 6fzd7vs9ee
3. 1394808-20-8
4. Unii-6fzd7vs9ee
5. Chembl4593911
6. 4-morpholineacetamide, N-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-, Hydrochloride (1:2)
7. Schembl12486477
8. Lcpqctbhzpmvfx-uhfffaoysa-n
9. Bdbm50517497
10. Akos040754117
11. Ms-28053
12. Hy-120124
13. Cs-0070018
14. N-[4-(1-cyclobutyl Piperidin-4-yloxy)phenyl]-2-(morpholin-4-yl) Acetamide Dihydrochloride
15. N-[4-(1-cyclobutylpiperidin-4-yl)oxyphenyl]-2-morpholin-4-ylacetamide;dihydrochloride
Molecular Weight | 446.4 g/mol |
---|---|
Molecular Formula | C21H33Cl2N3O3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 54 |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 463 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?